4.7 Article

Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma

Related references

Note: Only part of the references are listed.
Article Microbiology

Development and Validation of an In Vitro Resazurin-Based Susceptibility Assay against Madurella mycetomatis

S. O. Abd Algaffar et al.

Summary: An in vitro susceptibility assay for Madurella mycetomatis hyphae using resazurin for endpoint reading was presented, with itraconazole and posaconazole showing the lowest MICs. Results were comparable to a XTT-based susceptibility assay, showing less effectiveness for amphotericin B, micafungin, and terbinafine.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Public, Environmental & Occupational Health

In vitro susceptibility testing for black grain eumycetoma causative agents

Wendy W. J. van de Sande

Summary: Eumycetoma is a neglected tropical disease characterized by subcutaneous swellings caused by fungal infection. In vitro susceptibility assays have been developed for causative agents, mainly used for determining inhibition of growth by antifungal agents. However, a clear correlation between in vitro inhibition and therapeutic efficacy has not been established, requiring further research.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2021)

Article Biochemistry & Molecular Biology

Niclosamide Is Active In Vitro against Mycetoma Pathogens

Abdelhalim B. Mahmoud et al.

Summary: Redox-active drugs are key in parasite chemotherapy, and the study found that niclosamide showed significant activity against Madurella mycetomatis and Actinomadura spp. Further evaluation of salicylanilides, particularly niclosamide, is proposed as drug repurposing candidates for mycetoma treatment.

MOLECULES (2021)

Article Dermatology

Actinomycetoma by Actinomadura madurae: Clinical characteristics and treatment of 47 cases

Alexandro Bonifaz et al.

Summary: This retrospective study analyzed 47 cases of actinomycetoma, finding that the foot was the most affected region with a high rate of bone invasion. The most commonly used and effective treatment scheme was found to be streptomycin + sulfamethoxazole-trimethoprim with dapsone, resulting in a 63% clinical and mycological cure rate.

INDIAN DERMATOLOGY ONLINE JOURNAL (2021)

Review Dermatology

Mycetoma: An Update

Vineet Relhan et al.

INDIAN JOURNAL OF DERMATOLOGY (2017)

Review Dermatology

Eumycetoma and actinomycetoma - an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy

P. Nenoff et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)

Letter Dermatology

Abdomino-pelvic actinomycetoma successfully treated with combination chemotherapy

Sumit Kar et al.

AUSTRALASIAN JOURNAL OF DERMATOLOGY (2014)

Review Infectious Diseases

Mycetoma Medical Therapy

Oliverio Welsh et al.

PLOS NEGLECTED TROPICAL DISEASES (2014)

Review Infectious Diseases

Global Burden of Human Mycetoma: A Systematic Review and Meta-analysis

Wendy W. J. van de Sande

PLOS NEGLECTED TROPICAL DISEASES (2013)

Article Dermatology

Actinomycetoma and advances in its treatment

Oliverio Welsh et al.

CLINICS IN DERMATOLOGY (2012)

Article Microbiology

Variable antibiotic susceptibility patterns among Streptomyces species causing actinomycetoma in man and animals

Mohamed E. Hamid

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2011)

Review Dermatology

Developments in the management of mycetomas

M. Ameen et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2009)

Article Microbiology

In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis

A Gomez-Flores et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)

Article Microbiology

In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis

L Vera-Cabrera et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)

Article Biochemistry & Molecular Biology

Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity

J O'Brien et al.

EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)